4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-034670
President, CEO bought 2,000 shares at $7.29 ($14,580)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gilad Oren President, CEO | 2024-03-13 | Purchase | +2,000 | $7.29 | $14,580 | 324,770 | D |
| Derivatives | |||||||
| Gilad Oren President, CEO | 2024-03-13 | Purchase · Tranche A Warrant | +1,000 | 1,000 | D | ||
| Gilad Oren President, CEO | 2024-03-13 | Purchase · Tranche B Warrant | +1,000 | 1,000 | D | ||
| Open-market purchases · 2,000 sh · avg $7.29 · $14,580 | |||||||
Loading xslF345X05/tm248935-1_4seq1.xml…